Wednesday's pre-market session: top gainers and losers
By Mill Chart
Last update: Apr 24, 2024
Stay updated with the stocks that are on the move in Wednesday's pre-market session.
Pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| CSSE | 86.15% | Exciting news for CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) as their shares soared 86.15% to $0.28 during the pre-market session on Wednesday. The stock is trading 56.71% lower than 6 months ago. |
| RILY | 30.29% | B. RILEY FINANCIAL INC's (NASDAQ:RILY) shares rose 30.29% to $28.3. NASDAQ:RILY is releasing earnings today. Shareholders saw the stock price going 39.65% lower is the past 6 months. |
| PEB | 22.98% | Exciting news for PEBBLEBROOK HOTEL TRUST (NYSE:PEB) as their shares soared 22.98% to $19.0 during the pre-market session on Wednesday. Yesterday the company had a press release: Pebblebrook Hotel Trust Reports First Quarter 2024 Results. |
| SOUNW | 21.14% | SOUNDHOUND AI INC (NASDAQ:SOUNW) rose 21.14% to $2.12 during Wednesday's pre-market session. Today's pre-market session shows a continuation of the previous session's success for NASDAQ:SOUNW, with a 21.14% increase following yesterday's 37.8% gain. |
| TPET | 20.8% | Exciting news for TRIO PETROLEUM CORP (NYSEARCA:TPET) as their shares soared 20.8% to $0.43 during the pre-market session on Wednesday. Shareholders saw the stock price going 282.0% higher in the past month. |
| WIMI | 18.56% | During Wednesday's pre-market trading, WIMI HOLOGRAM CLOUD INC-ADR (NASDAQ:WIMI) demonstrated strong momentum, with the stock price rising 18.56% to $0.86. In the last month the stock lost 23.19%. |
| VRT | 17.47% | VERTIV HOLDINGS CO-A (NYSE:VRT) experienced an impressive 17.47% increase in share price, reaching $93.0 during the pre-market session on Wednesday. yesterday the company released their earnings. Earlier today the company had a press release: Vertiv Reports 60% Organic Orders Growth, 8% Net Sales Growth in First Quarter; Updates Full Year 2024 Outlook. |
| AEYE | 16.47% | AUDIOEYE INC's (NASDAQ:AEYE) shares rose 16.47% to $15.7. Also in the previous session NASDAQ:AEYE had a very good day: shares closed with a 13.76% gain. |
| IMMP | 15.54% | Pre-market trading on Wednesday showed positive momentum for IMMUTEP LTD-SP ADR (NASDAQ:IMMP), as the stock price advanced 15.54% to reach $2.9. The stock is trading 34.22% higher than 6 months ago. |
| AZ | 15.04% | During Wednesday's pre-market trading, A2Z SMART TECHNOLOGIES CORP (NASDAQ:AZ) demonstrated strong momentum, with the stock price rising 15.04% to $0.52. Today's pre-market session builds upon the previous day's success, as NASDAQ:AZ continues its upward trajectory following a 12.82% gain. |
For the full premarket gainers list go to our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| DCFC | -62.91% | Investors observed a 62.91% decline in TRITIUM DCFC LTD's (NASDAQ:DCFC) stock price, which now stands at $1.35 during Wednesday's pre-market session. Shareholders saw the stock price going 73.62% lower in the past month. |
| FN | -24.46% | FABRINET's (NYSE:FN) shares experienced a 24.46% decline, falling to $127.42 during Wednesday's pre-market session. Two days ago the company had a press release: Fabrinet to Announce Third Quarter Fiscal Year 2024 Financial Results on May 6, 2024. |
| LUCY | -17.29% | Wednesday's pre-market session showed a 17.29% decrease in the stock price of INNOVATIVE EYEWEAR INC (NASDAQ:LUCY), reaching $0.21. In the last 3 months the stock lost 39.59%. |
| OVID | -15.31% | The stock price of OVID THERAPEUTICS INC (NASDAQ:OVID) is declining by 15.31%, reaching $2.71 during Wednesday's pre-market session. |
| NKGN | -13.51% | NKGEN BIOTECH INC's (NASDAQ:NKGN) shares experienced a 13.51% decline, falling to $1.6 during Wednesday's pre-market session. Following an impressive 25.85% run-up in yesterday's session, NASDAQ:NKGN experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. |
| CSLR | -13.51% | Despite yesterday's decline, COMPLETE SOLARIA INC (NASDAQ:CSLR) experienced a further 13.51% decrease in share price during Wednesday's pre-market session, reaching $0.37. Prices are quite volatile now: this is a reversal from yesterday's 10.51% gain. |
| OST | -13.4% | Today's pre-market session reveals a 13.4% decline in the stock price of OSTIN TECHNOLOGY GROUP CO LT (NASDAQ:OST), now priced at $0.43. After a strong performance yesterday with a 25.0% gain, NASDAQ:OST shows signs of retracement with a 13.4% decline in today's pre-market session. |
| HWH | -13.25% | During Wednesday's pre-market session, the shares of HWH INTERNATIONAL INC (NASDAQ:HWH) declined by 13.25%, reaching $1.31. The current market conditions exhibit high volatility as NASDAQ:HWH retraces its steps after yesterday's 17.97% gain. |
| KPRX | -12.96% | KIORA PHARMACEUTICALS INC's (NASDAQ:KPRX) shares fell 12.96% to $0.5 during Wednesday's pre-market session. Yesterday's 19.48% gain in NASDAQ:KPRX gives way to a 12.96% decrease in today's pre-market session, showcasing market fluctuations. |
| APDN | -10.45% | The stock price of APPLIED DNA SCIENCES INC (NASDAQ:APDN) is declining by 10.45%, reaching $0.26 during Wednesday's pre-market session. The downward trend from yesterday's -12.12% drop persisted in today's pre-market session, with another decline of 10.45% for NASDAQ:APDN. |
For the full premarket loser list go to our premarket losers page.
OVID THERAPEUTICS INC
NASDAQ:OVID (5/3/2024, 7:10:46 PM)
After market: 3.06 0 (0%)3.06
-0.01 (-0.33%)
OVID News
11 days ago - ChartmillWednesday's pre-market session: top gainers and losersStay updated with the stocks that are on the move in Wednesday's pre-market session.
a month ago - Ovid Therapeutics Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference2 months ago - Ovid Therapeutics Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsTwo pivotal Phase 3 clinical trials studying soticlestat as a treatment for Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) completed enrollment;...
2 months ago - Ovid Therapeutics Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer...
3 months ago - Ovid Therapeutics Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer...
5 months ago - Ovid Therapeutics Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)Posters with new preclinical data on the pharmacokinetic and pharmacodynamic behavior of OV329 support its profile as a potential best-in-class GABA...
6 months ago - Ovid Therapeutics Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesReceived a $30 million payment from Ligand for the sale of a 13% interest in the potential future royalties and milestone payments owed to Ovid for...
